vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Howard Hughes Holdings Inc. (HHH). Click either name above to swap in a different company.

Howard Hughes Holdings Inc. is the larger business by last-quarter revenue ($235.9M vs $121.8M, roughly 1.9× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs 3.4%, a 0.8% gap on every dollar of revenue. On growth, Howard Hughes Holdings Inc. posted the faster year-over-year revenue change (18.4% vs -1.4%). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -13.8%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.

CLB vs HHH — Head-to-Head

Bigger by revenue
HHH
HHH
1.9× larger
HHH
$235.9M
$121.8M
CLB
Growing faster (revenue YoY)
HHH
HHH
+19.8% gap
HHH
18.4%
-1.4%
CLB
Higher net margin
CLB
CLB
0.8% more per $
CLB
4.2%
3.4%
HHH
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-13.8%
HHH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
HHH
HHH
Revenue
$121.8M
$235.9M
Net Profit
$5.1M
$8.1M
Gross Margin
Operating Margin
1.5%
121.6%
Net Margin
4.2%
3.4%
Revenue YoY
-1.4%
18.4%
Net Profit YoY
-25.6%
EPS (diluted)
$0.11
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
HHH
HHH
Q1 26
$121.8M
$235.9M
Q4 25
$138.3M
$624.4M
Q3 25
$134.5M
$390.2M
Q2 25
$130.2M
$260.9M
Q1 25
$123.6M
$199.3M
Q4 24
$129.2M
$935.0M
Q3 24
$134.4M
$327.1M
Q2 24
$130.6M
$317.4M
Net Profit
CLB
CLB
HHH
HHH
Q1 26
$5.1M
$8.1M
Q4 25
$4.9M
$6.0M
Q3 25
$14.2M
$119.5M
Q2 25
$10.6M
$-12.1M
Q1 25
$-154.0K
$10.5M
Q4 24
$7.4M
$156.3M
Q3 24
$11.7M
$72.8M
Q2 24
$9.0M
$21.1M
Gross Margin
CLB
CLB
HHH
HHH
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
HHH
HHH
Q1 26
1.5%
121.6%
Q4 25
11.5%
4.2%
Q3 25
15.6%
48.6%
Q2 25
11.7%
26.0%
Q1 25
3.6%
24.0%
Q4 24
11.0%
33.5%
Q3 24
14.7%
60.6%
Q2 24
12.3%
20.4%
Net Margin
CLB
CLB
HHH
HHH
Q1 26
4.2%
3.4%
Q4 25
3.6%
1.0%
Q3 25
10.6%
30.6%
Q2 25
8.2%
-4.7%
Q1 25
-0.1%
5.3%
Q4 24
5.7%
16.7%
Q3 24
8.7%
22.2%
Q2 24
6.9%
6.6%
EPS (diluted)
CLB
CLB
HHH
HHH
Q1 26
$0.11
$0.14
Q4 25
$0.11
$0.20
Q3 25
$0.30
$2.02
Q2 25
$0.22
$-0.22
Q1 25
$0.00
$0.21
Q4 24
$0.15
$3.14
Q3 24
$0.25
$1.46
Q2 24
$0.19
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
HHH
HHH
Cash + ST InvestmentsLiquidity on hand
$22.8M
$1.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$3.8B
Total Assets
$587.7M
$11.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
HHH
HHH
Q1 26
$22.8M
$1.8B
Q4 25
$22.7M
$1.5B
Q3 25
$25.6M
$1.5B
Q2 25
$31.2M
$1.4B
Q1 25
$22.1M
$493.7M
Q4 24
$19.2M
$596.1M
Q3 24
$21.5M
$400.7M
Q2 24
$17.7M
$436.8M
Total Debt
CLB
CLB
HHH
HHH
Q1 26
Q4 25
$110.3M
$5.1B
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
$5.1B
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
HHH
HHH
Q1 26
$275.1M
$3.8B
Q4 25
$266.0M
$3.8B
Q3 25
$271.3M
$3.8B
Q2 25
$261.3M
$3.6B
Q1 25
$253.4M
$2.8B
Q4 24
$246.6M
$2.8B
Q3 24
$250.7M
$2.6B
Q2 24
$240.3M
$3.0B
Total Assets
CLB
CLB
HHH
HHH
Q1 26
$587.7M
$11.2B
Q4 25
$584.0M
$10.6B
Q3 25
$591.4M
$10.7B
Q2 25
$602.1M
$10.3B
Q1 25
$591.5M
$9.3B
Q4 24
$585.1M
$9.2B
Q3 24
$600.5M
$9.4B
Q2 24
$597.8M
$9.9B
Debt / Equity
CLB
CLB
HHH
HHH
Q1 26
Q4 25
0.41×
1.35×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
1.85×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
HHH
HHH
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
HHH
HHH
Q1 26
$4.0M
Q4 25
$7.9M
$360.3M
Q3 25
$8.5M
$149.8M
Q2 25
$13.9M
$177.3M
Q1 25
$6.7M
$-224.9M
Q4 24
$20.6M
$337.1M
Q3 24
$13.1M
$248.3M
Q2 24
$17.1M
$-17.5M
Free Cash Flow
CLB
CLB
HHH
HHH
Q1 26
$517.0K
Q4 25
$5.0M
$348.6M
Q3 25
$6.5M
$137.7M
Q2 25
$10.4M
$169.7M
Q1 25
$3.9M
$-238.4M
Q4 24
$17.4M
$317.1M
Q3 24
$10.4M
$238.7M
Q2 24
$14.3M
$-25.1M
FCF Margin
CLB
CLB
HHH
HHH
Q1 26
0.4%
Q4 25
3.6%
55.8%
Q3 25
4.8%
35.3%
Q2 25
8.0%
65.1%
Q1 25
3.1%
-119.6%
Q4 24
13.4%
33.9%
Q3 24
7.7%
73.0%
Q2 24
10.9%
-7.9%
Capex Intensity
CLB
CLB
HHH
HHH
Q1 26
Q4 25
2.1%
1.9%
Q3 25
1.5%
3.1%
Q2 25
2.7%
2.9%
Q1 25
2.3%
6.8%
Q4 24
2.5%
2.1%
Q3 24
2.0%
2.9%
Q2 24
2.2%
2.4%
Cash Conversion
CLB
CLB
HHH
HHH
Q1 26
0.77×
Q4 25
1.61×
60.04×
Q3 25
0.60×
1.25×
Q2 25
1.31×
Q1 25
-21.35×
Q4 24
2.78×
2.16×
Q3 24
1.12×
3.41×
Q2 24
1.90×
-0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

HHH
HHH

Rental revenue$113.5M48%
Master Planned Communities land sales$99.6M42%
Other revenues$11.0M5%
Builder price participation$8.7M4%
Condominium rights and unit sales$3.1M1%

Related Comparisons